{
  "id": "5dddb10d-91c2-4efb-a07d-ead30a2ebb50",
  "answer": "Neuren Pharmaceuticals Limited has a balanced company news read. Its latest completed weekly trend is positive.",
  "status": "balanced",
  "as_of": "2026-08-17T14:55:56.794103+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "ASX:NEU",
    "name": "Neuren Pharmaceuticals Limited (NEU)",
    "identity": {
      "sharemaestro_id": "1a99e02c-8452-4827-a2f2-f2d86b6c6b7f",
      "canonical_name": "Neuren Pharmaceuticals Limited",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "NEU"
      ],
      "provider_symbols": {
        "eodhd": [
          "NEU.AU"
        ],
        "yahoo": "NEU.AX",
        "market": "ASX",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Australia",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 50.0,
  "confidence": 15,
  "evidence_count": 7,
  "independent_sources": 2,
  "freshest_evidence": "2026-08-17T08:15:00+00:00",
  "previous_read": 50.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "NEU",
    "company": "Neuren Pharmaceuticals Limited",
    "country": "Australia",
    "currency": "AUD",
    "exchange": "ASX",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 7,
    "trend_state": "positive",
    "latest_close": "23.450001",
    "score_change": 0.0,
    "weekly_change": 3.213,
    "evidence_status": "provisional",
    "sentiment_score": 50
  },
  "canonical_url": "https://sharemaestro.com/evidence/5dddb10d-91c2-4efb-a07d-ead30a2ebb50/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/"
    },
    {
      "label": "Technicals & Market Dynamics",
      "url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technicals/"
    },
    {
      "label": "Technical Research Pack",
      "url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technical-pack/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=NEU"
    }
  ],
  "related_research": {
    "type": "price_technicals_and_market_dynamics",
    "name": "Technicals & Market Dynamics",
    "publisher": "Sharemaestro",
    "framework": "Market Dynamics",
    "methodology": "proprietary",
    "scope": "completed-week price structure and underlying market support",
    "period_end": "2026-08-14",
    "url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technicals/",
    "technical_pack_url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technical-pack/",
    "technical_pack_pdf_url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technical-pack/download.pdf",
    "technical_pack_data_url": "https://sharemaestro.com/terminal/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/technical-pack/data.json",
    "description": "Sharemaestro's proprietary completed-week analysis of whether underlying market support is strengthening or weakening beneath price. It complements this company-news record and is not an input to the news score.",
    "relationship": "complementary_research",
    "included_in_news_score": false
  },
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "7e06d2310a466c9138b1c9dd3233a23ea9054972af5491f76764de10ef8c09c9",
  "citation": "Sharemaestro, Neuren Pharmaceuticals Limited (NEU), 2026-08-17, https://sharemaestro.com/evidence/5dddb10d-91c2-4efb-a07d-ead30a2ebb50/"
}